GlobeStar Therapeutics

(OTC) GSTC

Current Price$0.00

Market Cap$1.20K

Since IPO (2016)-100%

5 Year-100%

1 Year+0%

1 Month+0%

GlobeStar Therapeutics Financials at a Glance

Market Cap

$1.20K

Revenue (TTM)

$0.00

Net Income (TTM)

-$888.00K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-29.59 (Low)

Dividend

$0.00

Beta (Volatility)

-29.59 (Low)

Price

$0.00

Volume

250

Open

$0.00

Price

$0.00

Volume

250

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Oct 11, 2024

Dividend

$0.00

Beta (Volatility)

-29.59 (Low)

Price

$0.00

Volume

250

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Oct 11, 2024

GSTC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GlobeStar Therapeutics

Industry

Biotechnology

Sector

Health Care

CEO

James C. Katzaroff

Website

www.globestartherapeutics.com

Headquarters

Richland, WA 99352, US

GSTC Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.20K

Shares Outstanding

1.24B

Volume

250

Avg. Volume

11.35K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$1.86M

EBITDA

$6.72K

Operating Cash Flow

-$205.76K

Capital Expenditure

$0.00

Free Cash Flow

-$205.76K

Cash & ST Invst.

$0.00

Total Debt

$366.01K

GlobeStar Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.20K

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$198.00K

+84.6%

EBITDA

$357.00

-94.7%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Total Cash

$41.00

N/A

Total Debt

$329.05K

+1972.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$329.05K

+1972.3%

Return on Assets

0.00%

N/A

Return on Invested Capital

1.30%

N/A

Free Cash Flow

-$20.40K

+49.2%

Operating Cash Flow

-$20.40K

+49.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RGMPRegnum Corp.

RGMPRegnum Corp.$0.00+0.00%

ACUSAcusphere, Inc.

ACUSAcusphere, Inc.$0.00+0.00%

BIOAFBioasis Technologies Inc.

BIOAFBioasis Technologies Inc.$0.00+0.00%

PBLAPanbela Therapeutics, Inc.

PBLAPanbela Therapeutics, Inc.$0.01+0.00%

HTDSHard to Treat Diseases Inc.

HTDSHard to Treat Diseases Inc.$0.00+0.00%

GBLXGB Sciences, Inc.

GBLXGB Sciences, Inc.$0.00+0.00%

IRBSIR Biosciences Holdings Inc.

IRBSIR Biosciences Holdings Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

INTCIntel

INTCIntel$124.57+0.07%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About GSTC

What is the current price of GlobeStar Therapeutics?

GlobeStar Therapeutics is trading at $0.00 per share.

What is the 52-week range for GlobeStar Therapeutics?

Over the past 52 weeks, GlobeStar Therapeutics has traded between $0.00 and $0.00.

How much debt does GlobeStar Therapeutics have?

As of the most recent reporting period, GlobeStar Therapeutics reported total debt of $325.62K.

How much cash does GlobeStar Therapeutics have on hand?

GlobeStar Therapeutics reported $41.00 in cash and cash equivalents in its most recent financial results.

What is GlobeStar Therapeutics’s dividend yield?

GlobeStar Therapeutics does not currently have a dividend yield.

GlobeStar Therapeutics

GlobeStar Therapeutics Financials at a Glance

GSTC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About GlobeStar Therapeutics

GSTC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

GlobeStar Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GSTC

What is the current price of GlobeStar Therapeutics?

What is the 52-week range for GlobeStar Therapeutics?

How much debt does GlobeStar Therapeutics have?

How much cash does GlobeStar Therapeutics have on hand?

What is GlobeStar Therapeutics’s dividend yield?

Premium Investing Services